Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Watkins Tim
CMO & Head of Development at Contineum Therapeutics. Filing since 29 Dec 2025.
CIK 0002065965
Company
Date
Role
Action
Shares
Amount
Of holding
CTNM
Contineum Therapeutics, Inc.
30 Jun 2026
CMO & Head of Development
Sold on a plan
10,833
$173.59K
54.7%
CTNM
Contineum Therapeutics, Inc.
2 Mar 2026
CMO & Head of Development
Sold on a plan
3,611
$54.22K
100%
CTNM
Contineum Therapeutics, Inc.
28 Jan 2026
CMO & Head of Development
Sold on a plan
3,611
$51.19K
100%
CTNM
Contineum Therapeutics, Inc.
29 Dec 2025
CMO & Head of Development
Sold on a plan
3,611
$43.56K
100%
4 decisions on file.
